ISLR and non-small cell lung carcinoma: In NSCLC patients and mouse syngeneic tumor models, large numbers of meflin+ CAFs attracted greater CD4+ T cell infiltration and promoted tumor angiogenesis, which in turn enhanced the response of NSCLC to immune checkpoint blockade therapy [195].